RISPERDAL CONSTA 12.5 MG VIAL
FDA nonproprietary name: risperidone
For 1 unit (EA)
Pharmacies pay
$317.93 filed
1 × $317.93143 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$981.65 filed
1 × $981.6488 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.1× estimated
Medicare paid 3.1× what pharmacies pay.
Part D averages every strength and form sold under “Risperdal Consta” / “Risperidone Microspheres” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$370.62 estimated
$317.93 + $47.69 (15%) + $5.00 fee per fill = $370.62
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
RISPERDAL CONSTA 12.5 MG VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as risperidone, under the trade name “RISPERDAL CONSTA”.
FDA gives its dosage form as kit.
The labeler, the company named on the label, is Janssen Pharmaceuticals, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 50458-0309-11.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $317.93 for 1 unit (EA) (1 × $317.93143 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The NDC
- 50458-0309-11 · Janssen Pharmaceuticals, Inc. · $317.93143 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
30 other products in the NADAC file share the FDA nonproprietary name risperidone with RISPERDAL CONSTA 12.5 MG VIAL. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| RISPERDAL 0.5 MG TABLET | $4.38113 per EA filed | We don’t know yet |
| RISPERDAL 1 MG TABLET | $4.69073 per EA filed | We don’t know yet |
| RISPERDAL 1 MG/ML SOLUTION | $5.28293 per ML filed | We don’t know yet |
| RISPERDAL 2 MG TABLET | $7.86404 per EA filed | We don’t know yet |
| RISPERDAL 3 MG TABLET | $9.20606 per EA filed | We don’t know yet |
| RISPERDAL 4 MG TABLET | $12.35264 per EA filed | We don’t know yet |
| RISPERDAL CONSTA 12.5 MG VIAL this page | $317.93143 per EA filed | $981.6488 per EA filed |
| RISPERDAL CONSTA 25 MG VIAL | $636.878 per EA filed | $981.6488 per EA filed |
| RISPERDAL CONSTA 37.5 MG VIAL | $949.93769 per EA filed | $981.6488 per EA filed |
| RISPERDAL CONSTA 50 MG VIAL | $1,273.39195 per EA filed | $981.6488 per EA filed |
| RISPERIDONE 0.25 MG ODT | $2.55281 per EA filed | $2.99892 per EA filed |
| RISPERIDONE 0.25 MG TABLET | $0.03684 per EA filed | $0.27086 per EA filed |
| RISPERIDONE 0.5 MG ODT | $1.00228 per EA filed | $2.99892 per EA filed |
| RISPERIDONE 0.5 MG TABLET | $0.03629 per EA filed | $0.27086 per EA filed |
| RISPERIDONE 1 MG ODT | $1.15235 per EA filed | $2.99892 per EA filed |
| RISPERIDONE 1 MG TABLET | $0.03661 per EA filed | $0.27086 per EA filed |
| RISPERIDONE 1 MG/ML SOLUTION | $0.47238 per ML filed | We don’t know yet |
| RISPERIDONE 2 MG ODT | $1.21992 per EA filed | $2.99892 per EA filed |
| RISPERIDONE 2 MG TABLET | $0.05444 per EA filed | $0.27086 per EA filed |
| RISPERIDONE 3 MG ODT | $1.31722 per EA filed | $2.99892 per EA filed |
| RISPERIDONE 3 MG TABLET | $0.06863 per EA filed | $0.27086 per EA filed |
| RISPERIDONE ER 25 MG VIAL | $355.23159 per EA filed | $533.10 per EA derived |
| RISPERIDONE ER 37.5 MG VIAL | $566.40385 per EA filed | $799.65 per EA derived |
| RISPERIDONE ER 50 MG VIAL | $760.21785 per EA filed | $1,066.20 per EA derived |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
What Medicare paid
Medicare Part D paid $981.65 for 1 unit (EA), at an average of $981.6488 per EA in 2024 (2024-01-01 to 2024-12-31) for “Risperdal Consta” and “Risperidone Microspheres”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 83,485 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for RISPERDAL CONSTA 12.5 MG VIAL labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Risperdal Consta / Risperidone Microspheres: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.